Phase 2 Trial of Gene Therapy, VY-AADC02,... - Cure Parkinson's
Phase 2 Trial of Gene Therapy, VY-AADC02, for Advanced Parkinson’s Enrolling in US
![Farooqji profile image](https://images.hu-production.be/avatars/d2bcede6695608a9d172b4c00f6b376c_small@2x_100x100.jpg)
Written by
![Farooqji profile image](https://images.hu-production.be/avatars/d2bcede6695608a9d172b4c00f6b376c_small@2x_100x100.jpg)
Farooqji
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Hope bioscience is enrolling in 2 clinical trials
bio/amp/two-clinical-trials-85-billion-stem-cells-and-a-whole-lot-of-hope-in-the-fight-against-parki
Potential disease-modifying therapy enters Phase 2
review of the data of the 101 trial, the drug advanced to the Phase II 201 trial (NCT05424276)....
Dr. Tom Foltynie of Cure Parkinson’s Addresses Bydureon (Exanatide) Phase III Trial.
was made in 2019 and contemplates starting the two year Phase III trial in October of 2019, but the...
Bayer reports positive early data for Parkinson’s cell therapy
clinical trial....
29% IMPROVEMENT in Alzheimer's using just 4 supplements in Phase 2 Clinical Study
---------------------------------------------
https://youtu.be/SWM5pyooBBg